New drug cocktail aims to stop cervical cancer comeback after surgery
Disease control
Not yet recruiting
This study tests whether a combination of two drugs (camrelizumab and famitinib) can help prevent cervical cancer from returning after surgery. It involves 30 women with specific cancer types and PD-L1 positive tumors. The main goal is to see how many patients remain cancer-free …
Phase: NA • Sponsor: Jin LI • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC